“…These programmable RNA-guided endonucleases (RGEN) are composed of two RNA elements, the CRISPR RNA (cRNA) and its transactivating RNA (tracRNA), which can be fused together through a linker sequence to provide greater flexibility both in the design and applicability of this technology 7 . The CRISPR-Cas9 system has been applied into a variety of gene modification processes in human cells, including targeted genome engineering 8,9 , transactivation and silencing module factors 10 , and genetic correction 11 , and has even been used as a platform to induce large chromosomal deletions or inversions 9,12 . However, to our knowledge CRISPR-Cas9 technology has not yet been adapted to generate human chromosomal translocations.…”